Unlock instant, AI-driven research and patent intelligence for your innovation.
Thiadiazole derivative
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A compound and pharmaceutical technology, applied in the field of medicine, can solve problems such as injury, side effects, and low cure rate
Inactive Publication Date: 2013-07-17
天津天诚新药评价有限公司
View PDF2 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Chemotherapy is faster, but the cure rate is very low
At the same time, it is clinically found that many anticancer drugs have obvious damage and side effects on the normal body, such as mutagenesis and genotoxicity
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0060] 2-(6,7-Dihydrothieno[3,2-c]pyridin-5(4H)-yl)-N-(5-(ethylthio)-1,3,4-thiadiazole-2 -base) the preparation of acetamide (compound I-1)
[0061]
[0062] Add 23.7g of intermediate III-1, 100mL of acetonitrile, 20.2g of triethylamine, and 17.5g of 4,5,6,7-tetrahydrothiophene [3,2] into a reaction flask equipped with stirring, condenser, and thermometer. -c] Pyridine hydrochloride, stirred at room temperature for 5 hours, washed the reaction solution with 3×50mL saturated brine, extracted with ethyl acetate, fully dried with anhydrous sodium sulfate, filtered, and evaporated to exhaust the ethyl acetate under reduced pressure, that is, Reddish-brown oil, separated by column [mobile phase: v (petroleum ether): v (ethyl acetate) = 3: 2], Rf = 0.51, and a white solid (HPLC: 99.4%) was obtained. 1 H NMR (CDCl 3 , 400MHz) δ: 1.311-1.347 (t, 3H, -CH 3 ), 2.481-2.499 (m, 2H, -CH 2 CH 2 -), 2.819-2.888 (m, 2H, -CH 2 CH 2 -), 3.184-3.239 (q, 2H, -CH 2 CO-), 3.546(s, 2H, -C...
Embodiment 2
[0068] Formation of compound 1 into hydrochloride: take 2.0 g of the white solid product of compound 1 and dissolve it in 10 mL of anhydrous ether. Cool in an ice-water bath to 0°C, add dropwise 25% diethyl ether solution of hydrochloric acid until the pH is 2, and continue to stir for about 1 h under an ice-water bath. Filter to obtain a white solid.
[0069] In order to more fully illustrate the pharmaceutical composition of the thiadiazole derivatives of the present invention, the following formulation examples are provided below, and the examples are for illustration only, and are not intended to limit the scope of the present invention.
Embodiment 3
[0071] Prepare hard gelatin capsules with the following ingredients:
[0072]
[0073] Preparation process: pre-dry the raw and auxiliary materials, and pass through a 100-mesh sieve for later use. The above ingredients are mixed according to the prescription amount and filled into hard gelatin capsules.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of anti-tumor medicaments, and provides a thiadiazole derivative with a structure of a formula I. In the formula I, R<1> is hydrogen, methyl and ethyl, and R<2> is the hydrogen, chlorine, bromine, the methyl, methylmercapto, ethylthio, methoxy carbonyl, carbethoxy, methoxyphenyl, bromophenyl and phenoxymethyl. The invention also relates to a preparation method for the compound, and discloses a medicinal composition in which a compound or a pharmaceutically-acceptable salt thereof are taken as active ingredients and application of the compound or the pharmaceutically-acceptable salt of the compound which serve as the anti-tumor medicaments.
Description
technical field [0001] The invention belongs to the technical field of medicine, more specifically, relates to a class of compounds with anti-tumor effect and their preparation method and application. Background technique [0002] Cancer has become a major chronic disease that seriously endangers human health. According to statistics, there are 9 million people who suffer from cancer every year in the world, and 6 million patients die from cancer. Almost one cancer patient dies every second. The annual incidence of cancer in my country is about 1.2 million, the number of cancer deaths is as high as more than 900,000, and the number of patients waiting for treatment exceeds 1.5 million, and there is an increasing trend year by year. Therefore, cancer has become the second largest killer after cardiovascular disease. Clinically, tumors are treated in three major ways: surgery, radiotherapy, and chemotherapy. Although the chemotherapy method is quicker, the cure rate is very...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.